As of March 2024 Evofem Biosciences has a market cap of $0.3 Million. This makes Evofem Biosciences the world's 8381th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.3 M | -56.27% |
2023 | $0.68 M | -87.44% |
2022 | $5.46 M | -91.04% |
2021 | $61.01 M | -68.85% |
2020 | $0.19 B | -34.05% |
2019 | $0.29 B | 174.04% |
2018 | $0.10 B | 301.29% |
2017 | $27 M | 74.39% |
2016 | $15.48 M | -18.96% |
2015 | $19.11 M | -81.31% |
2014 | $0.10 B |
On Mar 27th, 2024 the market cap of Evofem Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.82 B | 274,901.99% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $21.84 M | 7,172.98% | ๐บ๐ธ USA |